Drug Discovery Services Market Share, Trends, Demand, Revenue, Growth Drivers, Challenges and Competitive Analysis 2024-2033


Drug Discovery Services Market Share, Trends, Demand, Revenue, Growth Drivers, Challenges and Competitive Analysis 2024-2033: SPER Market Research

 Category : Healthcare

 Published: Apr-2024
 Author: SPER Analyst

Global Drug Discovery Outsourcing Market is projected to be worth USD 8.59 billion by 2033 and is anticipated to surge at a CAGR of 7.71%.

Finding, creating, and testing novel drugs to treat a range of illnesses is the laborious and complex process of drug discovery. Target identification, lead discovery, lead optimization, preclinical testing, clinical trials, and regulatory approval are some of the steps that are usually included in the process. Hiring a third-party company to handle all or part of the drug discovery process is known as outsourcing. Clinical studies and regulatory approval can also be done with it, albeit they are usually more complicated and may demand for more specialist knowledge. The two main services offered by outsourcing drug discovery are chemical and biological services. Pharmaceutical businesses can save money on overhead by outsourcing the requirement to hire specialist staff and purchase pricey laboratory equipment. 

Global Drug Discovery Outsourcing Market Driving Factors and Challenges
The market is growing thanks to AI-enabled drug discovery techniques and the growing R&D initiatives. The market is growing because to lower prices, more innovation penetration, and pharmaceutical firms working together on research. The process of finding new drugs is being made easier by the use of AI in organ-on-a-chip, digital organ simulation, and protein modeling. It is projected that the AI-driven medication discovery would lead to more capital investment in far-off places to grow their workforces for research and production. In addition, the new AI drug discovery outsourcing services should improve the creation of biomarkers, target identification, and patient stratification.

High medication development costs will impede market expansion. The high cost of drug development is one of the main reasons anticipated to impede the growth of the worldwide market for drug discovery outsourcing. The process of developing new drugs is costly, time-consuming, and requires several steps. The largest obstacle is the increased expenditures of preclinical research for medication development. Businesses invest a significant amount of money in research and development to find the target and then attach it to compounds that interest them. Pharmaceutical corporations invest millions on medication development, yet many treatments fail both early and late in clinical studies.

Impact of COVID-19 on Global Drug Discovery Outsourcing Market
A number of industries saw a significant decline in 2020 as a result of the COVID-19 pandemic's catastrophic effects on the overall economy. Among those most badly impacted by the outbreak was the healthcare sector, which was driven by the intense demand on medical facilities to contain the spread of disease. Several companies were found to have adjusted their R&D spending on clinical trials in comparison to previous investments. However, the rapid recovery was seen due to the increasing need for the development of a vaccine and effective drugs to treat COVID-19. But with the increasing need for the development of a vaccine and effective drugs to treat COVID-19, a speedy recovery was seen. 

Drug Discovery Outsourcing Market Key Players:
The market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players Charles River Laboratories, Curia Global Inc., Dalton Pharma Service, Discover X Corporation, Dr. Reddy’s Laboratories, Laboratory Corporation of America Holdings, Merck & Co, Syngene Intentional Ltd., Thermo Fisher Scientific,Inc., TCG Life Science Pvt. Ltd.

Global Drug Discovery Outsourcing Market Segmentation:

By Workflow: Based on the Workflow, Global Drug Discovery Outsourcing Market is segmented as; Target Validation and Functional Informatics, Lead Identification and Candidate Optimization, Preclinical Development, Target Identification and Screening, Others.

By Therapeutic Area: Based on the Therapeutic Area, Global Drug Discovery Outsourcing Market is segmented as; Cardiovascular, Central Nervous System, Gastrointestinal, Hematology, Respiration System, Infectious Disease, Oncology, Immunology, Others

By Drug Type: Based on the Drug Type, Global Drug Discovery Outsourcing Market is segmented as; Small Molecules, Large Molecules.

By End User: Based on the End User, Global Drug Discovery Outsourcing Market is segmented as; Pharmaceutical and Biotechnology Companies, Academia Institutes, Others.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Johnson & Johnson


Market Research

We are the leading, full-service global market research and consulting company.

iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]